A comprehensive evaluation in clinic and physiologically‐based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interaction potential for pomotrelvir
Abstract Pomotrelvir is a new chemical entity and potent direct‐acting antiviral inhibitor of the main protease of coronaviruses. Here the cytochrome P450 (CYP)-mediated drug-drug interaction (DDI) potential of pomotrelvir was evaluated for major CYP isoforms, starting with in vitro assays followed...
Saved in:
Main Authors: | Ziping Yang (Author), Nathalie Rioux (Author), Ludwig Vincent (Author), Hannah M. Jones (Author), David Cha (Author), Andrew Plummer (Author), David Wilfret (Author), Brian P. Kearney (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
by: Yiran Wang, et al.
Published: (2020) -
In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
by: Alexander V. Dmitriev, et al.
Published: (2021) -
Physiologically‐Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P‐glycoprotein and Cytochrome P450 3A
by: Yukio Otsuka, et al.
Published: (2020) -
Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 2.0
Published: (2021) -
Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes
by: Xiaokang Wang, et al.
Published: (2022)